FUS/TLS Activators

Common FUS/TLS Activators include, but are not limited to Tunicamycin CAS 11089-65-9, Thapsigargin CAS 67526-95-8, Dexamethasone CAS 50-02-2, Valproic Acid CAS 99-66-1 and 5-Aza-2′-Deoxycytidine CAS 2353-33-5.

FUS/TLS (Fused in Sarcoma/Translocated in Liposarcoma) is a multifunctional RNA/DNA-binding protein implicated in numerous cellular activities, including transcription, splicing, and transport of RNA. Structurally, FUS/TLS is characterized by its low-complexity domain and RNA recognition motifs, enabling it to partake in the formation of dynamic protein-RNA complexes and, under certain conditions, protein-protein interactions. In the cellular milieu, FUS/TLS is known to localize predominantly in the nucleus, where it exerts its primary roles. However, it can also shuttle to the cytoplasm, thereby participating in a broader range of cellular processes. Its ability to transition between cellular compartments and interact with various nucleic acid sequences underscores its pivotal role in maintaining RNA metabolism and cellular homeostasis.

FUS/TLS activators refer to molecules or compounds that enhance the activity, stability, or expression of FUS/TLS. By modulating the function of FUS/TLS, these activators can influence the intricate network of RNA processes in which FUS/TLS is involved. The mechanisms through which these activators exert their effects can be diverse: they might promote the binding affinity of FUS/TLS to its RNA targets, stabilize its structure, or upregulate its expression at the transcriptional or translational level. Understanding the nuances of FUS/TLS activators is crucial as it provides a window into the delicate balance of RNA metabolism within cells. As the scientific realm continues to explore the world of RNA-binding proteins, the importance of FUS/TLS and its activators becomes increasingly evident, offering a testament to the elaborate orchestration of cellular functions.